# OnCo record nykode-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nykode-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nykode-therapeutics" ;
  schema:name "Nykode Therapeutics"@en ;
  schema:description "Nykode makes cancer vaccines that teach the immune system to attack tumours. One is built from each patient's own tumour mutations; another targets cancers caused by the HPV16 virus, such as cervical cancer."@en ;
  schema:url <https://onco.cc/companies/nykode-therapeutics/>, <https://www.nykode.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.nykode.com>, <https://nykode.com/wp-content/uploads/2026/09/260827-Private-Placement-Completed.pdf>, <https://www.globenewswire.com/news-release/2023/04/18/2649342/0/en/nykode-therapeutics-announces-positive-final-results-from-its-phase-2-trial-of-vb10-16-in-combination-with-pd-l1-inhibitor-atezolizumab-in-advanced-cervical-cancer.html>, <https://www.globenewswire.com/news-release/2022/12/06/2568545/0/en/nykode-therapeutics-announces-clinical-collaboration-with-msd-to-evaluate-vb10-16-in-combination-with-keytruda-pembrolizumab-in-patients-with-hpv16-positive-head-and-neck-cancer.html> ;
  schema:addressCountry "NO" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/>, <https://onco.cc/technologies/shared-antigen-vaccine/> .